Cefazedone Sodium

头孢西酮钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefazedone Sodium
Drug Alias NameZenocefPazeronRefosporen
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSkin Diseases, Infectious +[5] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSkin Diseases, Infectious +[5] 
Approved Indications in ChinaComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSkin Diseases, Infectious +[5] 
Original Approved Country/TerritoryGermany
Original Approved Date1979/01/01
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShin Poong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSkin Diseases, Infectious +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01DB06
Related LinksWikipedia